Wie sind die bei Einnahme von VIAGRA® beobachteten Sehstörungen - Insbesondere bei Netzhautdegenerationen - zu werten?

Klinische Monatsblatter fur Augenheilkunde

Volumn 212, Issue 6, 1998, Pages

  Zrenner, Eberhart ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; PIPERAZINE DERIVATIVE; SILDENAFIL;

ARTICLE; CHEMICALLY INDUCED DISORDER; HUMAN; MALE; RETINA DEGENERATION; RISK FACTOR; VISUAL DISORDER;

ENZYME INHIBITORS; HUMANS; MALE; PIPERAZINES; RETINAL DEGENERATION; RISK FACTORS; VISION DISORDERS;

EID: 0032084409     PISSN: 00232165     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Schneider T., Kohen L., Zrenner E.: The effect of phosphodiesterase inhibitors on sensory retinal function in the arterially perfused cat eye and in man. In: Concepts Toxicol Vol. 4: Drug-induced ocular side effects and ocular toxicology, ed.: Hockwin O., Karger, Basel 183-192 (1987)
2. Schneider T., Zrenner E.: Der Einfluß von Phosphodiesterasehemmstoffen auf die Netzhautfunktion des arteriell perfundierten Auges. In: Fortschr. Ophthalmol. 82, 197-202 (1985)
3. Schneider T., Zrenner E.: The influence of phosphodiesterase inhibitors on ERG and optic nerve response of the cat. Invest. Ophthal. Vis. Sci. 27, 1395-1403 (1986).
4. Zrenner E., Kramer W., Bittner Ch., Bopp M., Schlepper M.: Rapid effects on colour vision, following intravenous injection of a new, non glycoside positive inotropic substance (AR-L 115 BS) Docum. Ophthalmol. Proc. Series 33:493-507 (1982)